These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17264506)

  • 1. Therapies based on principles of ocular immune privilege.
    Zhang-Hoover J; Stein-Streilein J
    Chem Immunol Allergy; 2007; 92():317-327. PubMed ID: 17264506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro-induced cell-mediated immune deviation to encephalitogenic antigens.
    Farooq SM; Ashour HM
    Brain Behav Immun; 2014 Jan; 35():64-9. PubMed ID: 24095895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vivo and in vitro induction of anterior chamber associated immune deviation to myelin antigens in C57BL/6 mice.
    Farooq SM; Elkhatib WF; Ashour HM
    Brain Behav Immun; 2014 Nov; 42():118-22. PubMed ID: 24953428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gammadelta T cells promote anterior chamber-associated immune deviation and immune privilege through their production of IL-10.
    Ashour HM; Niederkorn JY
    J Immunol; 2006 Dec; 177(12):8331-7. PubMed ID: 17142729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1.
    D'Orazio TJ; Mayhew E; Niederkorn JY
    J Immunol; 2001 Jan; 166(1):26-32. PubMed ID: 11123273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral tolerance via the anterior chamber of the eye: role of B cells in MHC class I and II antigen presentation.
    Ashour HM; Niederkorn JY
    J Immunol; 2006 May; 176(10):5950-7. PubMed ID: 16670303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.
    Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using tolerance induced via the anterior chamber of the eye to inhibit Th2-dependent pulmonary pathology.
    Katagiri K; Zhang-Hoover J; Mo JS; Stein-Streilein J; Streilein JW
    J Immunol; 2002 Jul; 169(1):84-9. PubMed ID: 12077232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-borne signals that induce anterior chamber-associated immune deviation after intracameral injection of antigen.
    Streilein JW; Okamoto S; Hara Y; Kosiewicz M; Ksander B
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2245-54. PubMed ID: 9344347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood.
    Wilbanks GA; Streilein JW
    J Immunol; 1991 Apr; 146(8):2610-7. PubMed ID: 1707912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Th1 and Th2 cells in anterior chamber-associated immune deviation.
    Li XY; D'Orazio LT; Niederkorn JY
    Immunology; 1996 Sep; 89(1):34-40. PubMed ID: 8911137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID).
    D'Orazio TJ; Niederkorn JY
    Immunology; 1998 Sep; 95(1):47-55. PubMed ID: 9767456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of ovalbumin-induced airway inflammation and hyperreactivity by tolerogenic APC.
    Zhang-Hoover J; Finn P; Stein-Streilein J
    J Immunol; 2005 Dec; 175(11):7117-24. PubMed ID: 16301614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta.
    Wilbanks GA; Mammolenti M; Streilein JW
    Eur J Immunol; 1992 Jan; 22(1):165-73. PubMed ID: 1530916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type.
    Hara Y; Okamoto S; Rouse B; Streilein JW
    J Immunol; 1993 Nov; 151(10):5162-71. PubMed ID: 8228216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nature of antigen in the eye has a profound effect on the cytokine milieu and resultant immune response.
    D'Orazio TJ; Niederkorn JY
    Eur J Immunol; 1998 May; 28(5):1544-53. PubMed ID: 9603459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type II Collagen-Specific B Cells Induce Immune Tolerance in Th1-Skewed, Th2-Skewed, and Arthritis-Prone Strains of Mice.
    Farooq SM; Ashour HM
    Cells; 2021 Apr; 10(4):. PubMed ID: 33921248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye.
    Streilein JW
    Eye (Lond); 1995; 9 ( Pt 2)():236-40. PubMed ID: 7556724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
    Yamada J; Zhu SN; Streilein JW; Dana MR
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerogenic APC generate CD8+ T regulatory cells that modulate pulmonary interstitial fibrosis.
    Zhang-Hoover J; Stein-Streilein J
    J Immunol; 2004 Jan; 172(1):178-85. PubMed ID: 14688324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.